Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Return on Sales (2021 - 2025)

PAVmed (PAVM) has 5 years of Return on Sales data on record, last reported at 1202.4% in Q3 2025.

  • For Q3 2025, Return on Sales changed N/A year-over-year to 1202.4%; the TTM value through Sep 2025 reached 49.31%, changed N/A, while the annual FY2024 figure was 9.49%, 4182.0% up from the prior year.
  • Return on Sales reached 1202.4% in Q3 2025 per PAVM's latest filing, up from 2053.83% in the prior quarter.
  • Across five years, Return on Sales topped out at 2527.5% in Q1 2021 and bottomed at 2053.83% in Q2 2025.
  • Average Return on Sales over 5 years is 30.05%, with a median of 49.81% recorded in 2023.
  • Peak YoY movement for Return on Sales: tumbled -263138bps in 2022, then skyrocketed 234620bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 65.6% in 2021, then tumbled by -234bps to 219.39% in 2022, then soared by 92bps to 16.59% in 2023, then surged by 788bps to 114.2% in 2024, then crashed by -1153bps to 1202.4% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 1202.4% in Q3 2025, 2053.83% in Q2 2025, and 2327.88% in Q1 2025.